Secreted Phosphoprotein 24 kD (Spp24) and Spp14 Affect TGF-β Induced Bone Formation Differently

Loading...
Thumbnail Image
Penn collection
Departmental Papers (Dental)
Degree type
Discipline
Subject
Adult
Animals
Bone Development
Humans
Kinetics
Peptide Fragments
Phosphoproteins
Protein Binding
Surface Plasmon Resonance
Transforming Growth Factor beta
bone morphogenetic protein
phosphoprotein
phosphoprotein 24
transforming growth factor alpha
transforming growth factor beta
transforming growth factor beta1
transforming growth factor beta2
unclassified drug
article
binding affinity
bioassay
bone development
bone disease
bone growth
bone metabolism
bone remodeling
bone turnover
carboxy terminal sequence
down regulation
histopathology
in vivo study
ossification
protein binding
protein interaction
protein secretion
surface plasmon resonance
Dental Materials
Dentistry
Endodontics and Endodontology
Oral and Maxillofacial Surgery
Oral Biology and Oral Pathology
Orthodontics and Orthodontology
Other Dentistry
Periodontics and Periodontology
Funder
Grant number
License
Copyright date
Distributor
Related resources
Author
Tian, Haijun
Bi, Xiaoda
Li, Chen-Shuang
Zhao, Ke-Wei
Brochmann, Elsa J.
Montgomery, Scott R.
Aghdasi, Bayan
Chen, Deyu
Daubs, Michael D.
Wang, Jeffrey C.
Contributor
Abstract

Transforming growth factor-β (TGF-β) and bone morphogenetic proteins (BMPs) have opposing but complementary functions in directing bone growth, repair, and turnover. Both are found in the bone matrix. Proteins that bind to and affect the activity of these growth factors will determine the relative abundance of the growth factors and, therefore, regulate bone formation. Secreted phosphoprotein 24 kD (Spp24) is a bone matrix protein that has been demonstrated to bind to and affect the activity of BMPs. The arginine-rich carboxy terminus of Spp24 is proteolytically processed to produce three other predictable truncation products (Spp18.1, Spp16.0, and Spp14.5). In this work, we report that kinetic data obtained by surface plasmon resonance demonstrate that Spp24 and the three C-terminal truncation products all bind to TGF-β1 and TGF-β2 with a similar but somewhat less affinity than they bind BMP-2; that, as in the case of BMP-2, the full-length (FL) form of Spp24 binds TGF-β with greater affinity than do the truncation products; that FL-Spp24 inhibits TGF-β2 induced bone formation in vivo, but Spp14.5 does not; and that co-administration of FL-Spp24 or Spp14.5 with TGF-β2 in vivo is associated with a reduction in the amount of cartilage, relative to new bone, present at the site of injection. This finding is consistent with the observation that low-dose TGF-β administration in vivo is associated with greater bone formation than high-dose TGF-β administration, and suggests that one function of Spp24 and its truncation products is to down-regulate local TGF-β activity or availability during bone growth and development. The similarities and differences of the interactions between Spp24 proteins and TGF-β compared to the interaction of the Spp24 proteins and BMPs have significant implications with respect to the regulation of bone metabolism and with respect to engineering therapeutic proteins for skeletal disorders. © 2013 Tian et al.

Advisor
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
2013-08-26
Journal title
PLoS ONE
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
At the time of publication, author Chenshuang Li was affiliated with the Peking University School and Hospital of Stomatology. Currently, (s)he is a faculty member at the School of Medical Dentistry at the University of Pennsylvania.
Recommended citation
Collection